Drug-induced rheumatic disorders: Incidence, prevention and management

Drug Safety

Volumn 23, Issue 4, 2000, Pages 279-293

  Vergne, P ^a   Bertin, P ^a   Bonnet, C ^a   Scotto, C ^a   Treves, R ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ALPHA INTERFERON; BCG VACCINE; CALCIUM; CIPROFLOXACIN; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; ETHAMBUTOL; ETRETINATE; FLUORIDE; FUROSEMIDE; HEPATITIS B VACCINE; HYDRALAZINE; INTERLEUKIN 2; ISOTRETINOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOBARBITAL; PROCAINAMIDE; PYRAZINAMIDE; QUINOLINE DERIVATIVE; RETINOID; RUBELLA VACCINE; SALICYLIC ACID; TESTOSTERONE; THIAZIDE DIURETIC AGENT; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG; VITAMIN D;

ANTIBACTERIAL ACTIVITY; ARTHROPATHY; BONE NECROSIS; CLINICAL FEATURE; CLINICAL TRIAL; DOSE RESPONSE; DRUG ABSORPTION; DRUG MECHANISM; GOUT; HUMAN; HYPERURICEMIA; INCIDENCE; NONHUMAN; OSTEOMALACIA; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TENDINITIS;

EID: 0033785129     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200023040-00002     Document Type: Review

References (96)

1. Fluoroquinolone antimicrobial agents
2. Adverse effects of the fluoroquinolones
3. Ciprofloxacine: An update on clinical experience
4. Tendinopathies et fluoroquinolones
5. Effets secondaires des fluoroquinolones. Etude retrospective sur l'annee 1992
6. Quinolone arthropathy. Acute toxicity to immature articular cartilage
7. Tolerance articulaire de la pefloxacine et de l'ofloxacine chez les enfants et adolescents atteints de mucoviscidose
8. Quinolones in children. Are concerns over arthropathy justified?
9. Safety of ciprofloxacin in children: World wide clinical experience based on compassionate use. Emphasis on joint evaluation
10. Safety of ciprofloxacin therapy in children: Magnetic resonance images, body fluid levels of fluoride and linear growth
11. Fluoroquinolone induced tendinopathy: Report of 6 cases
12. Ruptures tendineuses et fluoroquinolones: Un effet indesirable de classe
13. Apport de l'IRM dans les complications tendineuses des fluoroquinolones
14. Indomethacin treatment in osteoarthritis of hip joint. Does the treatment interfere with the natural course of the disease
15. Effect of non steroidal anti-inflammatory drugs on the course of osteoarthritis
16. Femoral-head height loss: A study of the relative significance of some of its determinants in hip degeneration
17. Anti-inflammatoires non steroidiens et cartilage
18. La coxopathie destructrice rapide idiopathique. Etude etiologique prospective de 27 cas
19. Effects of salicylates and other non-steroidal anti-inflammatory drugs on articular cartilage
20. Effects of some nonsteroidal anti-inflammatory drugs on proteoglycan metabolism and organization in canine articular cartilage
21. Effects of salicylate and indomethacin on glycosaminoglycan and prostaglandin E2 synthesis in intact canine knee cartilage ex vivo
22. Dangers of long-term use of NSAIDs in osteoarthritis
23. Cyclooxygenase inhibitors augment the production of pro-matrix metalloproteinase 9 (progelatinase B) in rabbit articular chondrocytes
24. The dose-related effects of phenylbutazone and a methylprednisolone acetate formulation (Depo-medrol) on cultured explants of equine carpal articular cartilage
25. Corticotrophins and corticosteroids
26. Charcot's arthropathy of the shoulder following intraarticular corticosteroid injection
27. Stimulation of proteoglycan synthesis by triamcinolone acetonide and insulin-like growth factor 1 in normal and arthritic murine articular cartilage
28. Corticosteroid injection in rheumatoid arthritis does not increase rate of total joint arthroplasty
29. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis
30. Intra-articular corticosteroids
31. Aspiration and injection of joints and soft tissues
32. Rheumatological symptoms due to retinoids
33. Hypercalcemia and skeletal effects in chronic hypervitaminosis A
34. Effects of retinoic acid on protein synthesis by foetal bovine chondrocytes in high-density culture: Down-regulation of the glucose-regulated protein, GRP-78, and type II collagen
35. Gout
36. The drug-induced rheumatisms
37. Drug-induced gout
38. Hyperuricemia and gout among heart transplant recipients receiving cyclosporine
39. Induced lupus
40. Drugs recently associated with lupus syndromes
41. Drug-induced lupus
42. The clinical utility of antihistone antibodies. Autoantibodies reactive with chromatin in systemic lupus erythematosus and drug-induced lupus
43. Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complexe
44. Phospholipid specificity of autoimmune and drug-induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease
45. Minocycline related lupus
46. New concepts in the pathogenesis of drug-induced lupus
47. Rubella-associated arthritis. 1. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation
48. Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines
49. Risk of chronic arthropathy among women after rubella vaccination
50. Randomised double-bind placebo-controlled study on adverse effects of rubella immunisation in seronegative women
51. Arthritis after hepatitis B vaccination: Report of three cases
52. Acute sero-positive rheumatoid arthritis occurring after hepatitis B vaccination
53. Vaccinations et rhumatismes
54. Arthropathies apres vaccin contre l'hepatite B
55. The development of rheumatoid arthritis after recombinant hepatitis B vaccination
56. Bacillus Calmette-Guerin induced aseptic arthritis: An experimental model of reactive arthritis
57. Reiter's syndrome after intravesical bacillus Calmette-Guerin treatment for superficial bladder carcinoma
58. A new side effect of BCG immunotherapy: BCG-induced arthritis in man
59. Thyroiditis after treatment with interleukin-2 and interferon alpha-2a
60. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors
61. Polyarthritis during interferon alpha therapy: 3 cases and review of the literature
62. Trois cas de polyarthrite survenant au cours d'un traitement par interferon-alpha recombinant
63. Arthritis in patients with psoriasis treated with gamma-interferon
64. Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy
65. Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty's syndrome
66. Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapy
67. Corticosteroid induced osteoporosis
68. Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease β-1 integrin levels
69. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
70. Drug-induced disorders of bone metabolism
71. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton
72. Diagnosis and treatment of glucocorticoid-induced osteoporosis
73. Alendronate for the management of glucocorticoid-induced osteoporosis: Results of the multicenter U.S. study
74. The effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with or without steroids
75. Testosterone therapy in glucocorticoid-treated men
76. Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid-induced osteoporosis?
77. Sodium monofluorophosphate increases vertebral bone mineral density in patients with corticosteroid-induced osteoporosis
78. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
79. Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases
80. Serum 25-hydroxy-calciferol levels and bone mass in children on chronic anti-convulsant therapy
81. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment
82. Calcium metabolism during rifampicine and isoniazid therapy for tuberculosis
83. An interesting case of osteomalacia due to antacid use associated with stainable bone aluminium in a patient with normal renal function
84. The treatment of osteoporosis with disodium ethane-1-hydroxy-1,1-diphosphonate
85. Focal osteomalacia due to low dose diphosphonate therapy in Paget's disease
86. Cyclic etidronate in the treatment of postmenopausal osteoporosis: Efficacy and safety after seven years of treatment
87. Bisphosphonates: Mechanisms of action
88. Histomorphometric analysis of a calcaneal stress fracture: A possible complication of fluoride therapy for osteoporosis
89. Osteonecrosis
90. Accumulative cell stress: The multi-factorial etiology of idiopathic osteonecrosis
91. Osteonecrosis of bone: Current concepts as to etiology and pathogenesis
92. Rheumatic symptoms during tuberculosis therapy
93. L'algodystrophie de l'isoniazide et de l'ethionamide
94. Frozen shoulder: A new delayed complication of protease inhibitors therapy
95. Adhesive capsulitis of the shoulder induced by protease inhibitor therapy. Three new cases